Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
IMMUNOVANT, INC. Reports FY 2026 Financial Results
2026-05-20
SEC Filing 10-K
(0001764013-26-000064)
Please check the link below for details.
Ticker mentioned:
IMVT
Source:
Original SEC Document β